中医学报
中醫學報
중의학보
China Journal of Chinese Medicine
2015年
5期
690-692
,共3页
封舟%瞿惠燕%戎靖枫%刘茜%单艳梅%周华
封舟%瞿惠燕%戎靖楓%劉茜%單豔梅%週華
봉주%구혜연%융정풍%류천%단염매%주화
心力衰竭%心肾同治方%Na+-K+ATP酶%Ca2+-Mg2+ATP酶%琥珀酸脱氢酶%血流动力学
心力衰竭%心腎同治方%Na+-K+ATP酶%Ca2+-Mg2+ATP酶%琥珀痠脫氫酶%血流動力學
심력쇠갈%심신동치방%Na+-K+ATP매%Ca2+-Mg2+ATP매%호박산탈경매%혈류동역학
heart failure%xinshentongzhi%Na+-K+ATPase%Ca2+-Mg2+ATPase%succinate dehydrogenase%hemodynamics
目的:观察心肾同治方对心力衰竭大鼠心功能的影响。方法:60只大鼠制备为心力衰竭模型,随机平均分为心肾同治方低剂量组、中剂量、高剂量组,曲美他嗪组,模型组,假手术组。造模2周后对除假手术对照组之外的大鼠进行药物灌胃8周。分析两种ATP酶活性及浓度、琥珀酸脱氢酶(succinodehydrogenase,SDH)值以及血流动力学参数。结果:与模型组比较,假手术组心肌左室内压上升最大速率及左室收缩压值均有所上升,同时心肌左室内压下降最大速率及左室舒张压表现为显著下降。心肾同治方中剂量组、高剂量组的左室收缩压、左室舒张压、心肌左室内压上升最大速率、心肌左室内压下降最大速率相关指标均接近于曲美他嗪组和假手术组,其中以高剂量组的改善尤为明显。对大鼠中药干预治疗后,实验数据显示其心肌Na+-K+ATP酶及Ca2+-Mg2+ATP酶和SDH的活力指标低于假手术组相关指标,但较模型组大鼠的指标有明显的提升。随着中药心肾同治方剂量的增加,心肌Na+-K+ATP酶、Ca2+-Mg2+ATP酶、SDH活力也逐渐增强;心肾同治方高剂量与曲美他嗪干预大鼠后的指标数据基本趋同。结论:心肾同治方在改善大鼠心力衰竭及提高其心功能的过程中,主要机制为:增加心肌Na+-K+ATP酶及Ca2+-Mg2+ATP酶分泌,提升SDH活力,改善心力衰竭大鼠血流动力学参数。
目的:觀察心腎同治方對心力衰竭大鼠心功能的影響。方法:60隻大鼠製備為心力衰竭模型,隨機平均分為心腎同治方低劑量組、中劑量、高劑量組,麯美他嗪組,模型組,假手術組。造模2週後對除假手術對照組之外的大鼠進行藥物灌胃8週。分析兩種ATP酶活性及濃度、琥珀痠脫氫酶(succinodehydrogenase,SDH)值以及血流動力學參數。結果:與模型組比較,假手術組心肌左室內壓上升最大速率及左室收縮壓值均有所上升,同時心肌左室內壓下降最大速率及左室舒張壓錶現為顯著下降。心腎同治方中劑量組、高劑量組的左室收縮壓、左室舒張壓、心肌左室內壓上升最大速率、心肌左室內壓下降最大速率相關指標均接近于麯美他嗪組和假手術組,其中以高劑量組的改善尤為明顯。對大鼠中藥榦預治療後,實驗數據顯示其心肌Na+-K+ATP酶及Ca2+-Mg2+ATP酶和SDH的活力指標低于假手術組相關指標,但較模型組大鼠的指標有明顯的提升。隨著中藥心腎同治方劑量的增加,心肌Na+-K+ATP酶、Ca2+-Mg2+ATP酶、SDH活力也逐漸增彊;心腎同治方高劑量與麯美他嗪榦預大鼠後的指標數據基本趨同。結論:心腎同治方在改善大鼠心力衰竭及提高其心功能的過程中,主要機製為:增加心肌Na+-K+ATP酶及Ca2+-Mg2+ATP酶分泌,提升SDH活力,改善心力衰竭大鼠血流動力學參數。
목적:관찰심신동치방대심력쇠갈대서심공능적영향。방법:60지대서제비위심력쇠갈모형,수궤평균분위심신동치방저제량조、중제량、고제량조,곡미타진조,모형조,가수술조。조모2주후대제가수술대조조지외적대서진행약물관위8주。분석량충ATP매활성급농도、호박산탈경매(succinodehydrogenase,SDH)치이급혈류동역학삼수。결과:여모형조비교,가수술조심기좌실내압상승최대속솔급좌실수축압치균유소상승,동시심기좌실내압하강최대속솔급좌실서장압표현위현저하강。심신동치방중제량조、고제량조적좌실수축압、좌실서장압、심기좌실내압상승최대속솔、심기좌실내압하강최대속솔상관지표균접근우곡미타진조화가수술조,기중이고제량조적개선우위명현。대대서중약간예치료후,실험수거현시기심기Na+-K+ATP매급Ca2+-Mg2+ATP매화SDH적활력지표저우가수술조상관지표,단교모형조대서적지표유명현적제승。수착중약심신동치방제량적증가,심기Na+-K+ATP매、Ca2+-Mg2+ATP매、SDH활력야축점증강;심신동치방고제량여곡미타진간예대서후적지표수거기본추동。결론:심신동치방재개선대서심력쇠갈급제고기심공능적과정중,주요궤제위:증가심기Na+-K+ATP매급Ca2+-Mg2+ATP매분비,제승SDH활력,개선심력쇠갈대서혈류동역학삼수。
Objective:Investigate the impacts made by Xinshengtongzhi with different dose content on the treatment of rats with heart fail-ure.Methods:The rats modeling was developed by following below procedure:60 rats randomly distributed into 6 groups averagely:Xin-shengtongzhi low-dose group,middle-dose group,and high-dose group,model group,sham operation group,and trimetazidine group,re-spectively.Rats was lavaged 2 weeks later.Then,after 8 weeks,the parameters indicating the changes of hemodynamic were studied,in-cluding:±LVdp/dtmax,LVSP,and LVEDP.Meanwhile,the levels of Na+-K+and Ca2+-Mg2+ATPases and the values of Succinate Dehydrogenase were also studied via the application of spectrophotometer.Results:By comparing model and sham operation groups,it appears clearly that the LVSP and +dp/dtmax of sham operation group was significantly decreased,and LVEDP and-dp/dtmin signifi-cantly increased after Xinshentongzhi interventions.The study on diastolic and contractility functions of myocardial were also carried out,the results indicate that these two parameters in middle and high dose group were close to those in trimetazidine group and sham group.Meanwhile,results show that high doses of Xinshentongzhi can significantly improve cardiac function.The contents of Ca2+-Mg2+ATPase,Na+-K+ATPase,and Succinate Dehydrogenase were higher than the model group after Xinshentongzhi interventions.On the other hands,the contents of Na+-K+and Ca2+-Mg2+ATPases and Succinate Dehydrogenase are associated with the does content of Xinshentongzhi,i.e.,these values are increased with the increasing dose of Xinshentongzhi.Conclusion:Xinshentongzhi can effectively improve the cardiac function of heart failure rats to some extent.